3 newsletters, ranked by editorial quality and how recently they published. Looking for something more specific? Search instead.
A weekly newsletter tracking AI and computational drug discovery, covering deals, startups, funding rounds and research papers in biopharma. Each issue pairs a main analytical essay with a roundup of recent industry news.
A daily-style biopharma newsletter offering commentary on therapeutics, regulatory oversight and clinical trials, organised around weekday themes. Readers get a short, opinionated take on industry developments such as biosimilar choices, regulator priorities and upcoming conference data.
A mix of original commentary on AI in drug discovery and biopharma, and weekly roundups of vaccine and epidemiology headlines. Readers get an analytical take on why AI hasn't yet improved R&D productivity, plus a digest of outbreak and vaccination news.
One short email a week with hand-picked newsletters from the index. Free, no spam, unsubscribe anytime.
